Traded Jan 6 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Dec 8, 2025 · Filed Dec 9, 2025
The CEO of Verastem sold $21K of Verastem shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$21,000
Shares × reported transaction price
34 days after results of Nov 4, 2025, 58 days before results of Feb 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Traded Jan 6 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Daniel Calkins (Chief Financial Officer) sold ~$629 of Verastem
Automatic saleBrian M Stuglik (Director) sold ~$5.4K of Verastem
Automatic sale